Skip to main content
NCBI home page
RNA logoLink to RNA
. 2000 Apr;6(4):571–583. doi: 10.1017/s1355838200992215

In vitro selection of novel RNA ligands that bind human cytomegalovirus and block viral infection.

J Wang 1, H Jiang 1, F Liu 1
PMCID: PMC1369938  PMID: 10786848

Abstract

Ribonuclease-resistant RNA molecules that bind to infectious human cytomegalovirus (HCMV) were isolated in vitro from a pool of randomized sequences after 16 cycles of selection and amplification. The two ligands (L13 and L19) characterized exhibited high HCMV-binding affinity in vitro and effectively inhibited viral infection in tissue culture. Their antiviral activity was also specific as they only reacted with two different strains of HCMV but not with the related herpes simplex virus 1 and human cells. These two ligands appeared to function as antivirals by blocking viral entry. Ultraviolet (UV) crosslinking studies suggested that L13 and L19 bind to HCMV essential glycoproteins B and H, respectively. Thus, RNA ligands that bind to different surface antigens of HCMV can be simultaneously isolated by the selection procedure. Our study demonstrates the feasibility of using these RNA ligands as a research tool to identify viral proteins required for infectivity and as an antiviral agent to block viral infection.

Full Text

The Full Text of this article is available as a PDF (808.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldick C. J., Jr, Shenk T. Proteins associated with purified human cytomegalovirus particles. J Virol. 1996 Sep;70(9):6097–6105. doi: 10.1128/jvi.70.9.6097-6105.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Britt W. J., Auger D. Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus. J Virol. 1986 Apr;58(1):185–191. doi: 10.1128/jvi.58.1.185-191.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chee M. S., Bankier A. T., Beck S., Bohni R., Brown C. M., Cerny R., Horsnell T., Hutchison C. A., 3rd, Kouzarides T., Martignetti J. A. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol. 1990;154:125–169. doi: 10.1007/978-3-642-74980-3_6. [DOI] [PubMed] [Google Scholar]
  4. Chen D. H., Jiang H., Lee M., Liu F., Zhou Z. H. Three-dimensional visualization of tegument/capsid interactions in the intact human cytomegalovirus. Virology. 1999 Jul 20;260(1):10–16. doi: 10.1006/viro.1999.9791. [DOI] [PubMed] [Google Scholar]
  5. Compton T., Nowlin D. M., Cooper N. R. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology. 1993 Apr;193(2):834–841. doi: 10.1006/viro.1993.1192. [DOI] [PubMed] [Google Scholar]
  6. Cranage M. P., Kouzarides T., Bankier A. T., Satchwell S., Weston K., Tomlinson P., Barrell B., Hart H., Bell S. E., Minson A. C. Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO J. 1986 Nov;5(11):3057–3063. doi: 10.1002/j.1460-2075.1986.tb04606.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ellington A. D., Szostak J. W. In vitro selection of RNA molecules that bind specific ligands. Nature. 1990 Aug 30;346(6287):818–822. doi: 10.1038/346818a0. [DOI] [PubMed] [Google Scholar]
  8. Ellington A. D., Szostak J. W. Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures. Nature. 1992 Feb 27;355(6363):850–852. doi: 10.1038/355850a0. [DOI] [PubMed] [Google Scholar]
  9. Gold L., Brown D., He Y., Shtatland T., Singer B. S., Wu Y. From oligonucleotide shapes to genomic SELEX: novel biological regulatory loops. Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):59–64. doi: 10.1073/pnas.94.1.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gold L., Polisky B., Uhlenbeck O., Yarus M. Diversity of oligonucleotide functions. Annu Rev Biochem. 1995;64:763–797. doi: 10.1146/annurev.bi.64.070195.003555. [DOI] [PubMed] [Google Scholar]
  11. Gretch D. R., Kari B., Rasmussen L., Gehrz R. C., Stinski M. F. Identification and characterization of three distinct families of glycoprotein complexes in the envelopes of human cytomegalovirus. J Virol. 1988 Mar;62(3):875–881. doi: 10.1128/jvi.62.3.875-881.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Guerrier-Takada C., Lumelsky N., Altman S. Specific interactions in RNA enzyme-substrate complexes. Science. 1989 Dec 22;246(4937):1578–1584. doi: 10.1126/science.2480641. [DOI] [PubMed] [Google Scholar]
  13. Homann M., Göringer H. U. Combinatorial selection of high affinity RNA ligands to live African trypanosomes. Nucleic Acids Res. 1999 May 1;27(9):2006–2014. doi: 10.1093/nar/27.9.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Huber M. T., Compton T. The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing envelope complex. J Virol. 1998 Oct;72(10):8191–8197. doi: 10.1128/jvi.72.10.8191-8197.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Irmiere A., Gibson W. Isolation of human cytomegalovirus intranuclear capsids, characterization of their protein constituents, and demonstration that the B-capsid assembly protein is also abundant in noninfectious enveloped particles. J Virol. 1985 Oct;56(1):277–283. doi: 10.1128/jvi.56.1.277-283.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jacobson M. A., Drew W. L., Feinberg J., O'Donnell J. J., Whitmore P. V., Miner R. D., Parenti D. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS. J Infect Dis. 1991 Jun;163(6):1348–1351. doi: 10.1093/infdis/163.6.1348. [DOI] [PubMed] [Google Scholar]
  17. Jellinek D., Green L. S., Bell C., Lynott C. K., Gill N., Vargeese C., Kirschenheuter G., McGee D. P., Abesinghe P., Pieken W. A. Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. Biochemistry. 1995 Sep 12;34(36):11363–11372. doi: 10.1021/bi00036a009. [DOI] [PubMed] [Google Scholar]
  18. Kubik M. F., Bell C., Fitzwater T., Watson S. R., Tasset D. M. Isolation and characterization of 2'-fluoro-, 2'-amino-, and 2'-fluoro-/amino-modified RNA ligands to human IFN-gamma that inhibit receptor binding. J Immunol. 1997 Jul 1;159(1):259–267. [PubMed] [Google Scholar]
  19. Lee S. W., Sullenger B. A. Isolation of a nuclease-resistant decoy RNA that can protect human acetylcholine receptors from myasthenic antibodies. Nat Biotechnol. 1997 Jan;15(1):41–45. doi: 10.1038/nbt0197-41. [DOI] [PubMed] [Google Scholar]
  20. Li L., Nelson J. A., Britt W. J. Glycoprotein H-related complexes of human cytomegalovirus: identification of a third protein in the gCIII complex. J Virol. 1997 Apr;71(4):3090–3097. doi: 10.1128/jvi.71.4.3090-3097.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lin Y., Nieuwlandt D., Magallanez A., Feistner B., Jayasena S. D. High-affinity and specific recognition of human thyroid stimulating hormone (hTSH) by in vitro-selected 2'-amino-modified RNA. Nucleic Acids Res. 1996 Sep 1;24(17):3407–3414. doi: 10.1093/nar/24.17.3407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lin Y., Qiu Q., Gill S. C., Jayasena S. D. Modified RNA sequence pools for in vitro selection. Nucleic Acids Res. 1994 Dec 11;22(24):5229–5234. doi: 10.1093/nar/22.24.5229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Liu F., Altman S. Differential evolution of substrates for an RNA enzyme in the presence and absence of its protein cofactor. Cell. 1994 Jul 1;77(7):1093–1100. doi: 10.1016/0092-8674(94)90448-0. [DOI] [PubMed] [Google Scholar]
  24. Liu F., Altman S. Inhibition of viral gene expression by the catalytic RNA subunit of RNase P from Escherichia coli. Genes Dev. 1995 Feb 15;9(4):471–480. doi: 10.1101/gad.9.4.471. [DOI] [PubMed] [Google Scholar]
  25. Meyer H., Masuho Y., Mach M. The gp116 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope. J Gen Virol. 1990 Oct;71(Pt 10):2443–2450. doi: 10.1099/0022-1317-71-10-2443. [DOI] [PubMed] [Google Scholar]
  26. Morris K. N., Jensen K. B., Julin C. M., Weil M., Gold L. High affinity ligands from in vitro selection: complex targets. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2902–2907. doi: 10.1073/pnas.95.6.2902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Navarro D., Paz P., Tugizov S., Topp K., La Vail J., Pereira L. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology. 1993 Nov;197(1):143–158. doi: 10.1006/viro.1993.1575. [DOI] [PubMed] [Google Scholar]
  28. Pachl C., Probert W. S., Hermsen K. M., Masiarz F. R., Rasmussen L., Merigan T. C., Spaete R. R. The human cytomegalovirus strain Towne glycoprotein H gene encodes glycoprotein p86. Virology. 1989 Apr;169(2):418–426. doi: 10.1016/0042-6822(89)90167-0. [DOI] [PubMed] [Google Scholar]
  29. Pagratis N. C., Bell C., Chang Y. F., Jennings S., Fitzwater T., Jellinek D., Dang C. Potent 2'-amino-, and 2'-fluoro-2'-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor. Nat Biotechnol. 1997 Jan;15(1):68–73. doi: 10.1038/nbt0197-68. [DOI] [PubMed] [Google Scholar]
  30. Palestine A. G., Polis M. A., De Smet M. D., Baird B. F., Falloon J., Kovacs J. A., Davey R. T., Zurlo J. J., Zunich K. M., Davis M. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med. 1991 Nov 1;115(9):665–673. doi: 10.7326/0003-4819-115-9-665. [DOI] [PubMed] [Google Scholar]
  31. Pan W., Craven R. C., Qiu Q., Wilson C. B., Wills J. W., Golovine S., Wang J. F. Isolation of virus-neutralizing RNAs from a large pool of random sequences. Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11509–11513. doi: 10.1073/pnas.92.25.11509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Pereira L., Hoffman M., Gallo D., Cremer N. Monoclonal antibodies to human cytomegalovirus: three surface membrane proteins with unique immunological and electrophoretic properties specify cross-reactive determinants. Infect Immun. 1982 Jun;36(3):924–932. doi: 10.1128/iai.36.3.924-932.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Pieken W. A., Olsen D. B., Benseler F., Aurup H., Eckstein F. Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes. Science. 1991 Jul 19;253(5017):314–317. doi: 10.1126/science.1857967. [DOI] [PubMed] [Google Scholar]
  34. Qadri I., Navarro D., Paz P., Pereira L. Assembly of conformation-dependent neutralizing domains on glycoprotein B of human cytomegalovirus. J Gen Virol. 1992 Nov;73(Pt 11):2913–2921. doi: 10.1099/0022-1317-73-11-2913. [DOI] [PubMed] [Google Scholar]
  35. Rasmussen L. E., Nelson R. M., Kelsall D. C., Merigan T. C. Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus. Proc Natl Acad Sci U S A. 1984 Feb;81(3):876–880. doi: 10.1073/pnas.81.3.876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Spaete R. R., Thayer R. M., Probert W. S., Masiarz F. R., Chamberlain S. H., Rasmussen L., Merigan T. C., Pachl C. Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology. 1988 Nov;167(1):207–225. doi: 10.1016/0042-6822(88)90071-2. [DOI] [PubMed] [Google Scholar]
  37. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990 Aug 3;249(4968):505–510. doi: 10.1126/science.2200121. [DOI] [PubMed] [Google Scholar]
  38. Verma S., Eckstein F. Modified oligonucleotides: synthesis and strategy for users. Annu Rev Biochem. 1998;67:99–134. doi: 10.1146/annurev.biochem.67.1.99. [DOI] [PubMed] [Google Scholar]
  39. Wiegand T. W., Williams P. B., Dreskin S. C., Jouvin M. H., Kinet J. P., Tasset D. High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I. J Immunol. 1996 Jul 1;157(1):221–230. [PubMed] [Google Scholar]
  40. Yang Q., Goldstein I. J., Mei H. Y., Engelke D. R. DNA ligands that bind tightly and selectively to cellobiose. Proc Natl Acad Sci U S A. 1998 May 12;95(10):5462–5467. doi: 10.1073/pnas.95.10.5462. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from RNA are provided here courtesy of The RNA Society

RESOURCES